Jeff Schaffnit: Sanofi Highlights Progress in Hemophilia and ITP at ISTH 2026
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“Looking back on the last few days, it’s clear that this year’s ISTH 2026 marked not only an important moment to reflect on the progress being made across rare blood disorders but also a time to reinforce the collective commitment driving innovation forward for patients.
I’m proud of the momentum Sanofi continues to build across our Rare Blood Disorders portfolio, from advances in hemophilia to continued progress in Immune Thrombocytopenia (ITP), where ongoing research is reshaping how we think about disease control.
What stands out most to me is what these milestones represent: years of collaboration among researchers, clinicians, patient communities and teams across Sanofi, all working toward the same goal of improving the day-to-day lives of people living with rare blood disorders.
Thank you to everyone whose dedication to chasing the miracles of science continues to turn scientific progress into meaningful impact for patients and families.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge